Lack of specific effects of selective D1 and D2 dopamine antagonists vs. risperidone on morphine-induced hyperactivity

Pharmacology Biochemistry and Behavior

Volumn 66, Issue 1, 2000, Pages 189-197

  Rodríguez Arias, Marta ^a   Broseta, Isolde ^a   Aguilar, M Asunción ^a   Miñarro, José ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Hyperactivity; Morphine; Raclopride; Risperidone; SCH 23390

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR BLOCKING AGENT; MORPHINE; RACLOPRIDE; RISPERIDONE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATALEPSY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG RECEPTOR BINDING; HYPERACTIVITY; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; CATALEPSY; DOPAMINE ANTAGONISTS; MALE; MICE; MORPHINE; MOTOR ACTIVITY; NARCOTICS; RACLOPRIDE; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RISPERIDONE;

ANIMALIA;

EID: 0342748576     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(00)00207-0     Document Type: Article

References (39)

1. Aguilar M.A., Rodríguez-Arias M., Marí-Sanmillán M.I., Miñarro J. Effects of risperidone on conditioned avoidance responding in male mice. Behav. Pharmacol. 8:1997;669-676.
2. Aguilar M.A., Miñarro J., Pérez-Iranzo N., Simón V.M. Behavioral profile of raclopride in agonistic encounters between male mice. Pharmacol. Biochem. Behav. 47:1994;753-756.
3. 2 dopamine receptor antagonism in a reaction-time task in rats. Neuropsychopharmacology. 8:1993;195-200.
4. Arnt J. Differential effects of classical and newer antipsychotics on the hypermotility induced by two dose levels of d-amphetamine. Eur. J. Pharmacol. 283:1995;55-62.
5. Arnt J., Skarsfeldt T., Hyttel J. Differentiation of classical and novel antipsychotics using animals models. Int. Clin. Psychopharmacol. 12:1997;S9-S17.
6. Bauco P., Wang Y., Wise R.A. Lack of sensitization or tolerance to the facilitating effect of ventral tegmental area morphine on lateral hypothalamic brain stimulation reward. Brain Res. 617:1993;303-308.
7. Casey D.E. Behavioral effects of sertindole, risperidone, clozapine and haloperidol in cebus monkeys. Psychopharmacology (Berlin). 124:1996;134-140.
8. Cunningham S.T., Kelley A.E. Opiate infusion into the nucleus accumbens. Contrasting effects on motor activity and responding for conditioned reward Brain Res. 588:1992;104-114.
9. Di Chiara G., Imperato A. Opposite effects of and opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J. Pharmacol. Exp. Ther. 244:1988;1067-1080.
10. ++ channel blockers on apomorphine, bromocriptine and morphine-induced locomotor activity in mice. Eur. J. Pharmacol. 364:1999;175-182.
11. Funada M., Suzuki T., Narita M., Misawa M., Nagase H. Modification of morphine-induced locomotor activity by pertussis toxin. Biochemical and behavioral studies in mice Brain Res. 619:1993;163-172.
12. Funada M., Suzuki T., Misawa M. The role of dopamine D1 receptors in morphine-induced hyperlocomotion in mice. Neurosci. Lett. 169:1994;1-4.
13. 2 and D2 dopamine receptor binding in the post-mortem human brain. An autoradiographic study. Eur. Neuropsychopharmacol. 5:1995;19-25.
14. Hertel P., Nomikos G.G., Iurlo M., Svensson T.H. Risperidone. Regional effects in vivo on release and metabolism of dopamine and serotonin in the rat brain Psychopharmacology (Berlin). 124:1996;74-86.
15. Imperato A., Obinu M.C., Casu M.A., Mascia M.S., Carta G., Gessa G.L. Chronic morphine increases hippocampal acetylcholine release. Possible relevance in drug dependence Eur. J. Pharmacol. 302:1996;21-26.
16. Iwamoto E.T. Locomotor activity and antinociception after putative and opioid receptor agonists in the rat. Influence of dopaminergic agonists and antagonists J. Pharmacol. Exp. Ther. 217:1981;451-460.
17. 1a receptor antagonists, WAY-100 635 and NDL-249, stimulate locomotion in rats acclimatised to their environment and alter their behaviour. A behavioural analysis Psychopharmacology (Berlin). 139:1998;300-310.
18. Janssen P.A.J., Niemegeers C.J.E., Awouters F., Schellekens K.H.L., Megens A.A.H.P., Meert T.F. Pharmacology of risperidone (R 64 766), a new antypsychotic with serotonin-S2 and dopamine-D2 antagonistic properties. J. Pharmacol. Exp. Ther. 244:1988;685-693.
19. Jeziorski M., White F.J. Dopamine receptor antagonists prevent expression, but not development of morphine sensitization. Eur. J. Pharmacol. 275:1995;235-244.
20. Kapur S., Remington G. Serotonin-dopamine interaction and its relevance to schizophrenla. Am. J. Psychiatry. 153:1996;466-476.
21. Kiritsy-Roy J.A., Standish S.M., Terry L.C. Dopamine D1 and D2 receptor antagonists potentiate analgesic and motor effects of morphine. Pharmacol. Biochem. Behav. 32:1989;717-721.
22. Lapin I.P., Rogawski M.A. Effects of D1 and D2 dopamine receptor antagonists and catecholamine depleting agents on the locomotor stimulation induced by dizocilpine in mice. Behav. Brain Res. 70:1995;145-151.
23. Longoni R., Spina L., Di Chiara G. Dopaminergic D1 receptors. Essential role in morphine-induced hypermotility Psychopharmacology (Berlin). 93:1987;401-402.
24. Magnus-Ellenbroek B., Havemann-Reinecke U. Morphine-induced hyperactivity in rats - A rebound effect? Naunyn Schmiedebergs Arch. Pharmacol. 347:1993;635-642.
25. Manzanedo C., Aguilar M.A., Miñarro J. The effects of dopamine D2 and D3 antagonists on spontaneous motor activity and morphine-induced hyperactivity in male mice. Psychopharmacology (Berlin). 143:1999;82-88.
26. Megens A.A.H.P., Awouters F.H.L., Schotte A., Meert T.F., Dugovic C., Niemegeers C.J.E., Leysen J.E. Survey of the pharmacodinamics of the new antipsychotic risperidone. Psychopharmacology (Berlin). 114:1994;9-23.
27. Narita M., Suzuki T., Funada M., Misawa M., Nagase H. Involvement of δ-opioid receptors in the effects of morphine on locomotor activity and the mesolimbic dopaminergic system in mice. Psychopharmacology (Berlin). 111:1993;423-426.
28. Narita M., Takahashi Y., Takamori K., Funada M., Suzuki T., Misawa M., Nagase H. Effects of k-agonist on the antinoception and locomotor enhancing action induced by morphine in mice. Jpn. J. Pharmacol. 62:1993;15-24.
29. Navarro J.F., Muñoz A., Miñarro J., Simón V.M. Absence of sensitisation to haloperidol in catalepsy of male mice. Med. Sci. Res. 20:1992;381-382.
30. Pickar D. Prospects for pharmacotherapy of schizophrenia. Lancet. 345:1995;557-562.
31. Rodríguez-Arias M., Miñarro J., Simón V.M. Interaction of morphine and haloperidol on agonistic and motor behaviors of male mice. Pharmacol. Biochem. Behav. 58:1997;153-158.
32. Rodríguez-Arias M., Miñarro J., Aguilar M.A., Pinazo J., Simón V.M. Effects of risperidone and SCH 23390 on isolation-induced aggression in male mice. Eur. Neuropsychopharmacol. 8:1998;95-103.
33. a maleate increases social behaviors of isolation-induced aggressive male mice. Psychopharmacology (Berlin). 144:1999;90-94.
34. Saller C.F., Czupryna M.J., Salama A.L. 5-HR2 receptor blockade by Id 169,369 and other 5.HT2 antagonists modulates the effects of D-2 dopamine receptor blockade. J. Pharmacol. Exp. Ther. 253:1990;1162-1170.
35. Schotte A., Janssen P.F.M., Gommeren W., Luyten W.H.M.L., Van Gompel P., Lesage A.S., De Loore L., Leysen J.E. Risperidone compared with new and reference antipsychotic drugs. In vitro and in vivo receptor binding Psychopharmacology (Berlin). 124:1996;57-73.
36. Sills T.L., Fletcher P.J. Fluoxetine attenuated morphine-induced locomotion and blocks morphine-sensitization. Eur. J. Pharmacol. 377:1997;161-164.
37. Spanagel R., Herz A., Bals-Kubik R., Shippenberg T.S. β-Endorphin-induced locomotor stimulation and reinforcement are associated with an increase in dopamine release in the nucleus accumbens. Psychopharmacology (Berkin). 104:1991;51-56.
38. Székely J.I., Miglécz E., Rónai A.Z. Biphasic effects of a potent analogue (D-Met2,Pro5)-enkephalinamide and morphine on locomotor activity in mice. Psychopharmacology (Berlin). 71:1980;299-301.
39. Vaccarino F.J., Amalric M., Swerdlow N.R., Koob G.F. Blockade of amphetamine but not opiate induced locomotion following antagonism of dopamine function in the rat. Pharmacol. Biochem. Behav. 24:1986;61-65.